MRP7/ABCC10expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer
Open Access
- 1 May 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 7 (5), 1150-1155
- https://doi.org/10.1158/1535-7163.mct-07-2088
Abstract
We used the paclitaxel-resistant human small cell lung cancer subline PC-6/TAX1-1, selected from PC-6 cells by paclitaxel, to test whether MRP7/ABCC10 (ABCC10) confers paclitaxel resistance. We found that gene expression of both ABCB1/MDR1 (ABCB1) and ABCC10 was higher in PC-6/TAX1-1 cells than in PC-6 cells. The expression levels of ABCC10 showed a significant inverse correlation with paclitaxel sensitivity (r = 0.574; P < 0.05) in 17 non-small cell lung cancer (NSCLC) cells unlike the expression levels of ABCB1. Pretreatment with the ABCC10 inhibitor sulfinpyrazone altered the sensitivity to paclitaxel in ABCC10-expressing NSCLC cells, concomitant with increased intracellular paclitaxel accumulation. These findings suggest that expression of the ABCC10 gene is induced by paclitaxel and that ABCC10 confers paclitaxel resistance by enhancing the efflux for paclitaxel. To confirm this hypothesis, we tested the effect on paclitaxel cytotoxicity of decreasing the expression of ABCC10 by small interfering RNA and found that this enhanced paclitaxel cytotoxicity in NCI-H23 cells concomitant with increased intracellular paclitaxel accumulation. These data indicate that ABCC10 may be one of the biomarkers for paclitaxel resistance in NSCLC. [Mol Cancer Ther 2008;7(5):1150–5]Keywords
This publication has 17 references indexed in Scilit:
- MRP8/ABCC11 directly confers resistance to 5-fluorouracilMolecular Cancer Therapeutics, 2007
- The determinants of sensitivity and acquired resistance to gemcitabine differ in non–small cell lung cancer: a role of ABCC5 in gemcitabine sensitivityMolecular Cancer Therapeutics, 2006
- Role of ABCG2 as a biomarker for predicting resistance to CPT-11/SN-38 in lung cancerCancer Science, 2006
- Targeting multidrug resistance in cancerNature Reviews Drug Discovery, 2006
- Analysis of the Drug Resistance Profile of Multidrug Resistance Protein 7 (ABCC10)Cancer Research, 2004
- Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung CancerThe New England Journal of Medicine, 2002
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- Expression of Drug Resistance‐related Genes in Head and Neck Squamous Cell Carcinoma and Normal MucosaJapanese Journal of Cancer Research, 2000
- Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen.JCI Insight, 1995
- The taxoids: paclitaxel and docetaxelThe Lancet, 1994